Dr. Tito Rodriguez Bouza

Educación y formación

• - 1 Legere HJ, 3rd, Palis RI, Rodriguez Bouza T, Uluer AZ, Castells MC: A safe protocol for rapid desensitization in patients with cystic fibrosis and antibiotic hypersensitivity. J Cyst Fibros 2009;8:418-424. 2 Brennan PJ, Rodriguez Bouza T, Hsu FI, Sloane DE, Castells MC: Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment. J Allergy Clin Immunol 2009;124:1259-1266. (Enlace a la revista) 3 Al-Ahmad M, Rodriguez Bouza T, Arifhodzic N: PCN allergy evaluation: experience from a drug allergy clinic in an Arabian Gulf Country, Kuwait. Asia Pac Allergy 2014;4:106-112. (Enlace a la revista) 4 Al-Ahmad M, Rodriguez Bouza T: Pattern of inpatient referrals to a drug allergy unit in Kuwait. Eur Ann Allergy Clin Immunol 2017;49:276-280. (Enlace a la revista) 5 Al-Ahmad M, Bouza TR: Successful desensitization to radiocontrast media in two high-risk cardiac patients. Ann Saudi Med 2017;37:333-335. (Enlace a la revista) 6 Al-Ahmad M, Rodriguez-Bouza T: Drug allergy evaluation for betalactam hypersensitivity: Cross-reactivity with cephalosporines, carbapenems and negative predictive value. Asian Pac J Allergy Immunol 2018;36:27-31. (Enlace a la revista) 7 Al Ahmad M, Arifhodzic N, Nurkic J, Jusufovic E, Hanoun AL, Rodriguez T: Role of nasal challenge and local eosinophilia in indirect exposure to cat in allergic rhinitis patients. Eur Ann Allergy Clin Immunol 2018;50:125-131. (Enlace a la revista) 8 Al-Ahmad M, Rodriguez-Bouza T, Fakim N, Pineda F: Extensive Cross-reactivity Between Salsola kali and Salsola imbricata. J Investig Allergol Clin Immunol 2018;28:29-36. (Enlace a la revista) 9 Al-Ahmad M, Rodriguez-Bouza T, Nurkic M: Establishing a Safe Administration of ASA in Cardiovascular Patients with Nonsteroidal Anti-Inflammatory Drug Hypersensitivity with Skin and/or Respiratory Involvement. Int Arch Allergy Immunol 2018;175:237-245. (Enlace a la revista) 10 Al-Ahmad M, Arifhodzic N, Nurkic J, Maher A, Rodriguez-Bouza T, Al-Ahmed N, Sadek A, Jusufovic E: «Real-life» Efficacy and Safety Aspects of 4-Year OMZ Treatment for Asthma. Med Princ Pract 2018;27:260-266. (Enlace a la revista) 11 Al-Ahmad M, Jusufovic E, Arifhodzic N, Rodriguez T, Nurkic J: Association of molds and metrological parameters to frequency of severe asthma exacerbation. Allergy Asthma Clin Immunol 2019;15:29. (Enlace a la revista) 12 Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs. The Journal of Allergy and Clinical Immunology: In Practice 2020:S117-S122. (Enlace a la revista) 13 Al-Ahmad M, Edin J, Musa F, Rodriguez-Bouza T. Drug Allergy Profile From a National Drug Allergy Registry. Front Pharmacol. 2021 Jan 8. (Enlace a la revista) 14. Al-Ahmad M, Jusufovic E, Arifhodzic N, Rodriguez-Bouza T: Peanut Component Ara h 1 and 2 Sensitization in Patients with Food Allergy in Kuwait. Int Arch Allergy Immunol 2021. (Enlace a la revista) 15 Al-Ahmad M, Al Rasheed M, Altourah L, Rodriguez-Bouza T, Shalaby N.: Isolated thrombosis after COVID-19 vaccination: case series. Int J Hematol. 2022 Feb (Enlace a la revista) 16 Al-Ahmad M, Al Rasheed M, Shalaby N, Rodriguez-Bouza T, Altourah L.: Immune Thrombocytopenia (ITP): Relapse Versus de novo After COVID-19 Vaccination. Clin Appl Thromb Hemost. 2022 Jan-Dec (Enlace a la revista)

Experiencia laboral

• - Licenciado en Medicina: Universidad Complutense de Madrid, España (1996 – 2003) Especialista en Alergología: Hospital Ramón y Cajal, Madrid, España (2004-2008) Doctorado «Cum Laude» (2011) , Investigación : Harvard University, Boston, USA . Título: Universidad de Alcalá de Henares, Madrid, España. «MODELO PREDICTVO IN VITRO DE DESENSIBILIZACIÓN RÁPIDA MASTOCITO-IgE: APLICACIÓN CLÍNICA A QUIMIOTERÁPICOS, ANTICUERPOS MONOCLONALES, ANTIBIÓTICOS Y ALIMENTOS EN PACIENTES CON ANAFILAXIA«

Idiomas en los que atiende

• - Inglés

• - Español

Sus especialidades

• - Alergólogo